Adenoviral-mediated expression of porphobilinogen deaminase in liver restores the metabolic defect in a mouse model of acute intermittent porphyria

This publication has 33 references indexed in Scilit:

• Non-viral delivery of the porphobilinogen deaminase cDNA into a mouse model of acute intermittent porphyria
  Molecular Genetics and Metabolism, 2004
• Liver transplantation as a cure for acute intermittent porphyria
  The Lancet, 2004
• Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene
  Clinical Genetics, 2002
• Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse
  Cancer Gene Therapy, 1999
• Characterization of Replication-Competent Adenovirus Isolates from Large-Scale Production of a Recombinant Adenoviral Vector
  Human Gene Therapy, 1999
• Imaging and tissue biodistribution of 99mTc-labeled adenovirus knob (serotype 5)
  Gene Therapy, 1998
• Acute Porphyria: Treatment with Heme
  Seminars in Liver Disease, 1998
• Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression
  Gene Therapy, 1997
• Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria
  Nature Genetics, 1996
• Assessment of Recombinant Adenoviral Vectors for Hepatic Gene Therapy
  Human Gene Therapy, 1993